THE PREVALENCE OF SERUM ANTIBODY TO HUMAN HERPESVIRUS-8 (KAPOSI SARCOMA-ASSOCIATED HERPESVIRUS) AMONG HIV-SEROPOSITIVE AND HIGH-RISK HIV-SERONEGATIVE WOMEN
Dh. Kedes et al., THE PREVALENCE OF SERUM ANTIBODY TO HUMAN HERPESVIRUS-8 (KAPOSI SARCOMA-ASSOCIATED HERPESVIRUS) AMONG HIV-SEROPOSITIVE AND HIGH-RISK HIV-SERONEGATIVE WOMEN, JAMA, the journal of the American Medical Association, 277(6), 1997, pp. 478-481
Objective.-To determine the prevalence of human herpesvirus 8 (HHV-8)
seropositivity among women who are known to be infected with human imm
unodeficiency virus type 1 (HIV-1) or who are at high risk for HIV inf
ection. Design.-A cross-sectional and blinded study of the prevalence
of serological reactivity to HHV-8 infection as determined by an indir
ect immunofluorescence assay using nuclei from cells latently infected
with HHV-8. Data and specimens were collected at baseline assessments
of a longitudinal natural history cohort study. Setting.-Four San Fra
ncisco Bay Area outpatient HIV specialty clinics participating in the
cohort study. Patients.-A total of 387 participants in the Women's Int
eragency HIV Study whose HIV infection status was documented and serum
was available in a local specimen repository. Main Outcome Measure.-S
erological reactivity to HHV-8. Results.-Serological reactivity to lat
ent HHV-8 antigens was uncommon among study participants: 13 (3.4%) de
monstrated serum antibodies. HHV-8 reactivity was more common among HI
V-infected women; 12 (4.0%; 95% confidence interval [CI], 2.1%-6.9%) o
f the 302 HIV-infected participants vs 1 (1.2%; 95% CI, 0.03%-6.4%) of
the 84 HIV-uninfected participants were seropositive for HHV-8, thoug
h the difference did not attain statistical significance (odds ratio=3
.43; 95% CI, 0.49-148.6). Two of the HIV-infected women had Kaposi sar
coma lesions and both were seropositive. Conclusions.-The prevalence o
f HHV-8 seropositivity among the group of HIV-infected women was drama
tically lower than that recently reported among HIV-infected homosexua
l and bisexual men (30%-35%). This finding parallels the lower prevale
nce of Kaposi sarcoma among women in contrast to men with HIV infectio
n. These data further extend the correlation of HHV-8 serological reac
tivity with risk of Kaposi sarcoma and are consistent with an importan
t role for HHV-8 infection in development of Kaposi sarcoma.